Unicycive Therapeutics, Inc. (UNCY) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Los Altos, CA, 美国. 现任CEO为 Shalabh K. Gupta.
UNCY 拥有 IPO日期为 2021-07-12, 22 名全职员工, 在 NASDAQ Capital Marke, 市值为 $149.15M.
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
